Literature DB >> 22488074

Radiographic progression in ankylosing spondylitis/axial spondyloarthritis: how fast and how clinically meaningful?

Denis Poddubnyy1, Joachim Sieper.   

Abstract

PURPOSE OF REVIEW: Radiographic progression in the axial skeleton is considered as an important outcome in ankylosing spondylitis (AS) and in the whole group of axial spondyloarthritis (SpA). Recently new data on the rates and predictors of radiographic progression from observational cohorts have become available. Here we summarize recent data and discuss their clinical relevance and directions for further investigations. RECENT
FINDINGS: Nonradiographic axial SpA progresses to AS with a rate of about 12% over 2 years; elevated C-reactive protein (CRP) is an important predictor of such a progression. The rate of radiographic progression in the spine is strongly dependent on the presence of the following risk factors: syndesmophytes at baseline, elevated acute phase reactants (CRP and/or erythrocyte sedimentation rate) and smoking. The presence of radiographic damage in the spine has a strong impact on spinal mobility and functional status, although the association of radiographic sacroiliitis progression with the functional status remains unclear.
SUMMARY: Radiographic progression in the spine and, to a lesser extent, in the sacroiliac joint represents a clinically relevant clinical outcome and treatment target in AS/axial SpA.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22488074     DOI: 10.1097/BOR.0b013e328352b7bd

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  21 in total

Review 1.  Current concept of spondyloarthritis: special emphasis on early referral and diagnosis.

Authors:  Salih Ozgocmen; Muhammad Asim Khan
Journal:  Curr Rheumatol Rep       Date:  2012-10       Impact factor: 4.592

2.  Anthrax toxin receptor 2 gene (ANTXR2) rs4333130 is associated with ankylosing spondylitis.

Authors:  Yanjuan Ou
Journal:  Int J Clin Exp Med       Date:  2015-05-15

3.  American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis.

Authors:  Michael M Ward; Atul Deodhar; Elie A Akl; Andrew Lui; Joerg Ermann; Lianne S Gensler; Judith A Smith; David Borenstein; Jayme Hiratzka; Pamela F Weiss; Robert D Inman; Vikas Majithia; Nigil Haroon; Walter P Maksymowych; Janet Joyce; Bruce M Clark; Robert A Colbert; Mark P Figgie; David S Hallegua; Pamela E Prete; James T Rosenbaum; Judith A Stebulis; Filip van den Bosch; David T Y Yu; Amy S Miller; John D Reveille; Liron Caplan
Journal:  Arthritis Rheumatol       Date:  2015-09-24       Impact factor: 10.995

Review 4.  Beyond the TNF-α Inhibitors: New and Emerging Targeted Therapies for Patients with Axial Spondyloarthritis and their Relation to Pathophysiology.

Authors:  Susanne Juhl Pedersen; Walter P Maksymowych
Journal:  Drugs       Date:  2018-09       Impact factor: 9.546

5.  Clinical efficacy and safety of adalimumab versus etanercept in patients with ankylosing spondylitis and total spinal ankylosis in Croatia: a multicentre 12-month follow-up study.

Authors:  Frane Grubišić; Đurđica Babić Naglić; Porin Perić; Jadranka Morović-Vergles; Branimir Anić; Tatjana Kehler; Srđan Novak; Marino Hanih; Ana Gudelj Gračanin; Nikolina Ljubičić Marković; Simeon Grazio
Journal:  Clin Rheumatol       Date:  2022-04-18       Impact factor: 3.650

6.  American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis.

Authors:  Michael M Ward; Atul Deodhar; Elie A Akl; Andrew Lui; Joerg Ermann; Lianne S Gensler; Judith A Smith; David Borenstein; Jayme Hiratzka; Pamela F Weiss; Robert D Inman; Vikas Majithia; Nigil Haroon; Walter P Maksymowych; Janet Joyce; Bruce M Clark; Robert A Colbert; Mark P Figgie; David S Hallegua; Pamela E Prete; James T Rosenbaum; Judith A Stebulis; Filip Van Den Bosch; David T Y Yu; Amy S Miller; John D Reveille; Liron Caplan
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-09-24       Impact factor: 4.794

7.  Tomography-guided palisade sacroiliac joint radiofrequency neurotomy versus celecoxib for ankylosing spondylitis: a open-label, randomized, and controlled trial.

Authors:  Yongjun Zheng; Minghong Gu; Dongping Shi; Mingli Li; Le Ye; Xiangrui Wang
Journal:  Rheumatol Int       Date:  2014-02-12       Impact factor: 2.631

8.  Diagnosis and progression of sacroiliitis in repeated sacroiliac joint computed tomography.

Authors:  Mats Geijer; Gro Gadeholt Göthlin; Jan H Göthlin
Journal:  Arthritis       Date:  2013-09-03

9.  Fat Metaplasia on Sacroiliac Joint Magnetic Resonance Imaging at Baseline Is Associated with Spinal Radiographic Progression in Patients with Axial Spondyloarthritis.

Authors:  Kwi Young Kang; In Je Kim; Min A Yoon; Yeon Sik Hong; Sung-Hwan Park; Ji Hyeon Ju
Journal:  PLoS One       Date:  2015-08-13       Impact factor: 3.240

10.  The prevalence of moderate to severe radiographic sacroiliitis and the correlation with health status in elderly Swedish men--the MrOS study.

Authors:  Sofia Exarchou; Inga Redlund-Johnell; Magnus Karlsson; Dan Mellström; Claes Ohlsson; Carl Turesson; Lars Erik Kristensen; Lennart Jacobsson
Journal:  BMC Musculoskelet Disord       Date:  2013-12-13       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.